Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof
US-11505597-B2 · Nov 22, 2022 · US
Coronaviridae (F)
Coronaviridae (F) · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/102 |
| Official title | Coronaviridae (F) |
| Display label | Coronaviridae (F) |
| Total patents | 169 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 9 |
| 2020 | 13 |
| 2021 | 18 |
| 2022 | 18 |
| 2023 | 39 |
| 2024 | 37 |
| 2025 | 16 |
| 2026 | 5 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
US-11345741-B2 · May 31, 2022 · US
Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection
US-11319382-B1 · May 3, 2022 · US
Compositions for preventing or treating viral and other microbial infections
US-2022119501-A1 · Apr 21, 2022 · US
DNA antibody constructs for use against middle east respiratory syndrome coronavirus
US-11230592-B2 · Jan 25, 2022 · US
ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES
US-2022017604-A1 · Jan 20, 2022 · US
Stereotypic neutralizing vh clonotypes against sars-cov-2 rbd in covid-19 patients and the healthy population
US-2021395346-A1 · Dec 23, 2021 · US
Compositions and methods for preventing and treating coronavirus infection - sars-cov-2 vaccines
US-2021388032-A1 · Dec 16, 2021 · US
Methods and uses of protein disulfide isomerase inhibitory compounds
US-2021353620-A1 · Nov 18, 2021 · US
Neutralizing Anti-SARS-CoV-2 Antibodies and Methods of Use Thereof
US-2021332110-A1 · Oct 28, 2021 · US
Compositions and methods for sequestering viruses
US-2021324414-A1 · Oct 21, 2021 · US
Sars-cov-2 surrogate virus neutralization assay test kit
US-2021302434-A1 · Sep 30, 2021 · US
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
US-2021300999-A1 · Sep 30, 2021 · US
Method for detecting MERS-CoV in Camilidae
US-11131672-B1 · Sep 28, 2021 · US
SARS-CoV-2 surrogate virus neutralization assay test kit
US-11112412-B1 · Sep 7, 2021 · US
Methods for quantitating individual antibodies from a mixture
US-2021268404-A1 · Sep 2, 2021 · US
Antibodies against sars-cov-2 and methods of using the same
US-2021261650-A1 · Aug 26, 2021 · US
Compositions and Methods for Preventing and Treating Coronavirus Infection - SARS-COV-2 Vaccines
US-2021246170-A1 · Aug 12, 2021 · US
Human Betacoronavirus Lineage C and Identification of N-Terminal Dipeptidyl Peptidase As Its Virus Receptor
US-2021246431-A1 · Aug 12, 2021 · US
SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein binding
US-11054429-B1 · Jul 6, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/102?
- CPC C07K16/102 is the Cooperative Patent Classification code for “Coronaviridae (F).”
- How many patents are filed under CPC C07K16/102 (Coronaviridae (F))?
- Our database includes 169 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/102 growing?
- Publication counts under this code: 37 in 2024 vs 16 in 2025 (latest complete years).